Axon Pharma

What Axon Pharma does

Axon Pharma is a private, independent regional pharmaceutical company headquartered in Las Condes, Santiago, Chile, with a subsidiary entity (AXON PHARMA S.A.S.) in Bogotá, Colombia. Founded in 2014, the company commercializes a diversified portfolio of pharmaceutical products in two core segments — Central Nervous System (CNS) and Over-the-Counter (OTC) — across multiple therapeutic areas including gastroenterology, neurology/psychiatry, otolaryngology, and pain management. Beyond prescription and OTC medicines, the portfolio extends to medical devices, dietary supplements, and cosmetics, all managed under a unified quality management system.

The company operates through direct commercial sales and distribution networks in Chile and Colombia, engaging healthcare professionals and patients with products sold through standard pharmaceutical supply chains. Its core operational differentiator is a rigorous pharmacovigilance system for safety monitoring and a quality framework covering promotion, acquisition, storage, and commercialization of regulated health products, compliant with local health authorities ISP (Chile) and INVIMA (Colombia). The go-to-market is sales-led, with healthcare providers and patients as the primary customer segments across all therapeutic and product categories.

Axon Pharma monetizes through one-time sales of pharmaceutical, supplement, device, and cosmetic products, with no disclosed subscription, licensing, or recurring-revenue model. Revenue figures, headcount progression, funding history, and customer accounts are not publicly disclosed; the company employs between 11 and 50 people based on available data, and presents itself as one of the fastest-growing firms in the regional pharmaceutical market. The business model is a traditional commercial-pharma distribution and marketing operation scaled across two Latin American countries.

Name

Axon Pharma

Legal name

AXON PHARMA S.A.S.

Website

https://axon-pharma.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

Axon Pharma is a private regional pharmaceutical company commercializing CNS, OTC, medical device, supplement, and cosmetic products across multiple therapeutic areas in Chile and Colombia through direct distribution networks.

Ownership category

akta.pro rank

Product category

Pharmaceutical Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIAAAF

Neurology & Psychiatry (CNS) Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Pharmaceutical products
• CNS medications
• OTC pharmaceuticals
• Medical devices
• Dietary supplements

Headquarters

HQ city

Las Condes

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of prescription and OTC pharmaceutical products across multiple therapeutic areas including CNS, gastroenterology, neurology/psychiatry, otolaryngology, and pain management.
2. Medical Devices: Commercialization of medical devices in regulated markets (Chile and Colombia).
3. Dietary Supplements: Sale of dietary supplements as part of the product portfolio.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Axon Pharma is a pharmaceutical laboratory company that develops, acquires, and commercializes a diversified portfolio of prescription and over-the-counter (OTC) pharmaceutical products, dietary supplements, medical devices, and cosmetics. The company operates with a primary focus on Central Nervous System (CNS/SNC) and OTC segments, spanning therapeutic areas such as gastroenterology, neurology/psychiatry, otolaryngology, and pain management, distributed in Chile and Colombia.

Product overview

Axon Pharma is a pharmaceutical laboratory company operating in Latin America (Chile and Colombia) with a diversified portfolio of pharmaceutical products, dietary supplements, medical devices, and cosmetics. The company operates in two primary segments: CNS (Central Nervous System) and OTC (Over-the-Counter). Their therapeutic areas include gastroenterology, neurology/psychiatry, otolaryngology, and pain management. The company is built on science and management standards with a focus on innovation and patient health outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical Products Portfolio
• Dietary Supplements
• Medical Devices
• Cosmetics

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Megalabs: Uruguay-headquartered regional pharmaceutical company with multi-country LatAm operations and a broad branded generics plus specialty portfolio. Highly comparable to Axon on geography, mid-cap scale, and multi-therapeutic breadth in Latin America.
• Laboratorios Bagó: Argentina-founded multinational pharma with deep presence across LatAm including Chile and Colombia, operating in similar specialty therapeutic areas. Comparable business model (independent regional pharma with branded portfolio) and overlap in target markets.
• Genomma Lab: Mexico-headquartered pharma company with strong OTC and consumer healthcare franchise across LatAm. Direct overlap with Axon's OTC/consumer-side revenue stream and similar multi-country go-to-market model.
• Laboratorios Asofarma: Mexican pharmaceutical group with branded specialty and OTC portfolio distributed across Latin America. Comparable mid-cap regional player with a similar mix of prescription pharmaceuticals and consumer healthcare products.
• Carnot Laboratorios: Mexican pharmaceutical manufacturer with branded specialty portfolio sold across Latin American markets. Similar independent-mid-cap profile and therapeutic-area breadth to Axon Pharma.

Broad incumbents

• Eurofarma: Brazil-based multinational pharmaceutical company with extensive LatAm footprint covering prescription, OTC and hospital lines. A much larger competitor operating in the same regional specialty-and-OTC categories where Axon competes.
• Lundbeck: Global CNS-specialty pharmaceutical company with active commercial operations in Chile and Colombia. A direct CNS-therapeutic peer whose CNS focus mirrors Axon's flagship segment, though operating at much larger scale.
• Teva Pharmaceutical: Global pharmaceutical company with both specialty and broad portfolio across LatAm, including OTC and CNS-adjacent lines. Comparable on category breadth but operates at much greater scale than Axon.
• Bayer (Consumer Health / Pharma LatAm): Global life sciences company with established prescription pharmaceutical and OTC consumer-health businesses across Latin America. Competitor in several of Axon's stated therapeutic categories (pain, GI, CNS-adjacent).

Emerging players

• Faes Farma: Spanish pharmaceutical company that has been expanding its branded specialty and OTC portfolio into Latin America. Similar size tier and CNS/nutraceutical-led mix to Axon with a parallel internationalization path.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axon Pharma